Telix Pharmaceuticals Limited Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised
Telix Pharmaceuticals Limited (TLPPF) had Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised of $125.41 million as of 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes › Income Taxes
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised · last filed 2026-02-20
- 2024-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 188.33M AUD.
- 2023-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 93.87M AUD.
AUD
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised |
|---|---|
| 2024-12-31 | 188.33M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 93.87M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised |
|---|---|
| 2025-12-31 | $125.41M 20-F · filed 2026-02-20 |
| 2024-12-31 | $112.85M 20-F · filed 2026-02-20 |